These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 22471425)
1. Identification of foreign bodies on the ocular surface after uneventful intravitreal injections. Jørgensen JS; Kemp H; Sørensen TL Acta Ophthalmol; 2012 Dec; 90(8):e646-7. PubMed ID: 22471425 [No Abstract] [Full Text] [Related]
2. Accuracy, precision and repeatability in preparing the intravitreal dose with a 1.0-cc syringe. Meyer CH; Liu Z; Brinkmann C; Rodrigues EB; Helb HM Acta Ophthalmol; 2012 Mar; 90(2):e165-6. PubMed ID: 21470379 [No Abstract] [Full Text] [Related]
3. Intravitreal ranibizumab, with or without filter? Montero JA; Ruiz-Moreno JM; Sanchis-Merino E Acta Ophthalmol; 2012 Aug; 90(5):e405-6. PubMed ID: 22008393 [No Abstract] [Full Text] [Related]
4. A new fractioning process to decrease the price of ranibizumab. González-Andrades M; Muñoz-Ávila JI; Medarde-Caballero C; Fernández-López C; Damas-Alonso M Acta Ophthalmol; 2012 Dec; 90(8):e645-6. PubMed ID: 22520334 [No Abstract] [Full Text] [Related]
5. Intravitreal administration of ranibizumab for idiopathic choroidal neovascularization in a pregnant woman. Sarhianaki A; Katsimpris A; Petropoulos IK; Livieratou A; Theoulakis PE; Katsimpris JM Klin Monbl Augenheilkd; 2012 Apr; 229(4):451-3. PubMed ID: 22496030 [No Abstract] [Full Text] [Related]
7. Intravitreal ranibizumab injection for choroidal neovascularization in Strümpell-Lorrain Syndrome. Tran TH; Baglin G; Querques G J Fr Ophtalmol; 2012 May; 35(5):353-5. PubMed ID: 22463854 [TBL] [Abstract][Full Text] [Related]
8. Same-day consecutive bilateral intravitreal injections of ranibizumab for the treatment of bilateral active choroidal neovascularization in age-related macular degeneration. Shah M; Amoaku WM Acta Ophthalmol; 2012 Sep; 90(6):e491-3. PubMed ID: 22269064 [No Abstract] [Full Text] [Related]
9. Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab. Willerslev A; Munch IC; Larsen M Acta Ophthalmol; 2012 Aug; 90(5):e407-9. PubMed ID: 22268957 [No Abstract] [Full Text] [Related]
10. [Alarming use of anti-VEGF therapy in premature infants]. Hård AL; Hellström A Lakartidningen; 2011 Dec 7-13; 108(49):2600. PubMed ID: 22468401 [No Abstract] [Full Text] [Related]
11. Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best's disease: 3-year follow-up. Ruiz-Moreno O; Calvo P; Ferrández B; Torrón C Acta Ophthalmol; 2012 Nov; 90(7):e574-5. PubMed ID: 22339886 [No Abstract] [Full Text] [Related]
12. Evaluation of signs and symptoms of ocular surface disease after intravitreal injection. Dohlman TH; Lertsuwanroj B; D'Amico DJ; Ciralsky JB; Kiss S Acta Ophthalmol; 2019 Dec; 97(8):e1154-e1156. PubMed ID: 31237739 [No Abstract] [Full Text] [Related]
13. [Spontaneous, bifocal rupture of the limbus in secondary angle closure glaucoma after open globe injury]. Schlote T; Landenberger H; Rohrbach JM Klin Monbl Augenheilkd; 2003 Nov; 220(11):787-90. PubMed ID: 14634905 [TBL] [Abstract][Full Text] [Related]
17. Failure to detect an effect of pneumatic displacement in the management of submacular haemorrhage secondary to age-related macular degeneration: a retrospective case series. Hesgaard HB; Torkashvand M; la Cour M Acta Ophthalmol; 2012 Sep; 90(6):e498-500. PubMed ID: 22268661 [No Abstract] [Full Text] [Related]
18. Evaluation of treatment efficacy of intravitreal ranibizumab injections in patients with wet type of AMD. Lubiński W; Mozolewska-Piotrowska K; Krasodomska K; Penkala K; Kaźmierczak B; Karczewicz D Klin Oczna; 2012; 114(3):187-93. PubMed ID: 23373399 [TBL] [Abstract][Full Text] [Related]